WO2022072846A2 - Plantes transgéniques ayant des profils d'acides gras modifiés et une biosynthèse d'hème régulée à la hausse - Google Patents
Plantes transgéniques ayant des profils d'acides gras modifiés et une biosynthèse d'hème régulée à la hausse Download PDFInfo
- Publication number
- WO2022072846A2 WO2022072846A2 PCT/US2021/053199 US2021053199W WO2022072846A2 WO 2022072846 A2 WO2022072846 A2 WO 2022072846A2 US 2021053199 W US2021053199 W US 2021053199W WO 2022072846 A2 WO2022072846 A2 WO 2022072846A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- seed
- heme
- nucleic acid
- transgenic plant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H5/00—Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
- A01H5/10—Seeds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
Definitions
- Plants make large amounts of tetrapyrrole molecules including chlorophyll, sirohemes and heme B.
- the tetrapyrrole biosynthetic pathway provides key co-factors and pigments for processes such as growth and essential redox reactions.
- Plants control tetrapyrrole synthesis by a number of routes, including a diurnal switch, a redox response system and negative feedback loops to prevent the formation of reactive oxidative species such as photoreactive intermediates, and to accurately distribute metabolic intermediates amongst end products of the pathway. (Mochizuki et al., Trends Plant Sci 15 (9): 488- 498, 2010).
- heme co-factor One molecule of the heme co-factor is typically synthesized for each polypeptide that is made. Therefore, in order to increase the specific production of heme B for incorporation into heme-containing proteins, it is important to separate the production of heme from the control mechanisms of the tetrapyrrole biosynthesis pathway, and specifically upregulate heme biosynthesis and not the other tetrapyrroles.
- Up-regulation in the context of heme biosynthesis refers to increased biosynthesis of heme without a corresponding increase in the biosynthesis of other tetrapyrroles.
- transgenic plant and seeds of the transgenic plant include at least one recombinant nucleic acid, wherein the recombinant nucleic acid includes: (i) a first promoter operably linked to a nucleic acid encoding a heme-containing polypeptide and; (ii) a second promoter operably linked to a nucleic acid encoding a polypeptide that upregulates heme biosynthesis, wherein heme-loading of the heme-containing polypeptide is increased in the transgenic plant relative to that of a corresponding control plant that does not comprise the second promoter operably linked to the nucleic acid encoding the polypeptide that upregulates heme biosynthesis, wherein the transgenic plant has a fatty acid profile selected from the group consisting of a high monounsaturated and/or a low polyunsaturated fatty acid content, a high medium chain fatty acid content, and a high saturated
- the first and second promoters are the same. In some embodiments, the first and second promoters are inducible. In some embodiments, the first and second promoters are seed specific promoters. In some embodiments, the seed specific promoter is selected from the group consisting of a soy beta-conglycinin seed specific promoter, a G1 -Glycinin seed specific promoter, a Kunitz trypsin inhibitor (KTI) promoter, and an oleosin promoter.
- KTI Kunitz trypsin inhibitor
- the recombinant nucleic acid further comprises a first targeting sequence operably linked to the nucleic acid encoding the heme-containing polypeptide, and a second targeting sequence operably linked to the nucleic acid encoding the polypeptide that upregulates heme biosynthesis.
- the first and second targeting sequences target the polypeptides to the same intracellular location within the transgenic plant. In some embodiments, the first and second targeting sequences are the same.
- the targeting sequence encodes a vacuole targeting signal peptide.
- the vacuole targeting signal peptide is a soy conglycinin vacuole targeting signal peptide, a soy glycinin vacuole targeting signal peptide, or a plant seed storage protein vacuole targeting signal peptide.
- the targeting sequence encodes a plastid targeting signal peptide.
- the plastid targeting signal peptide is a RuBisCO signal peptide.
- the targeting sequence is a soy beta-conglycinin targeting sequence.
- the targeting sequence is a G1 -Glycinin targeting sequence.
- the plant has a low polyunsaturated fatty acid content. In some embodiments, the bean or the seed has a low linolenic acid content. In some embodiments, the bean or the seed has a high monounsaturated fatty acid content. In some embodiments, the bean or the seed has a high oleic acid content. In some embodiments, the bean or the seed has a low unsaturated fatty acid content. In some embodiments, the bean or the seed has a high saturated fatty acid content. In some embodiments, the plant has a high monounsaturated fatty acid content and/or a low polyunsaturated fatty acid content. In some embodiments, the plant has a high medium chain fatty acid content. In some embodiments, the plant has a high saturated fatty acid content.
- a method of making a textured soy protein having reduced off-flavors can include obtaining a soy protein from a soybean plant yielding a seed oil with a high monounsaturated fatty acid content and/or a low polyunsaturated fatty acid content and processing the soy protein to obtain the textured soy protein.
- a method of making a textured soy protein having reduced off-flavors can include obtaining a soy protein from a soybean plant yielding a seed oil with a low linolenic acid content and processing the soy protein to obtain the textured soy protein.
- the methods further can include a step selected from the group consisting of: extracting the soy protein with supercritical CO2, extracting the soy protein with supercritical CO2 and a subsequent extraction with an organic solvent, fractioning the soy protein with ammonium-sulfate, and treating the soy protein with a cyclodextrin.
- a plant-based food composition comprising a hemecontaining polypeptide from the seeds is disclosed.
- the plantbased food composition is a meat substitute.
- the meat substitute is a beef substitute.
- the meat substitute is a chicken substitute.
- soybean protein is isolated from a soybean plant that yields a seed oil with a high monounsaturated fatty acid content and/or a low polyunsaturated fatty acid content.
- soybean protein is isolated from a soybean plant that yields a seed oil with a low linolenic acid content.
- soybean protein in another aspect, is isolated from a soybean plant having decreased expression and/or activity of one or more lipases, lipoxygenases, and/or hydroperoxide lyases.
- soybean protein in another aspect, is isolated from a soybean plant having decreased expression and/or activity of one or more lipases, lipoxygenases, and/or hydroperoxide lyases that yields a seed oil with a high monounsaturated fatty acid content and/or a low polyunsaturated fatty acid content.
- a genetically-modified plant comprising at least one genetic modification, wherein the genetic modification comprises an inversion of an endogenous nucleic acid, wherein the inversion results in i) a nucleic acid encoding a heme-containing polypeptide being operably linked to a nucleic acid encoding a seedspecific signal peptide and a seed-specific promoter of a seed-storage protein, and (ii) a nucleic acid encoding the seed-storage protein being operably linked to a promoter of the heme-containing polypeptide, wherein the heme-containing polypeptide is expressed in seeds of the plant and the seed-storage protein is expressed in root nodules of the plant.
- the genetically modified plant is a soy plant. In some embodiments, the genetically modified plant is a rice plant. In some embodiments, the genetically modified plant is selected from the group consisting of: a barley, a wheat, a corn, a rye, an oat, a beet, a sugar beet, a parsnip, a bean, a leafy vegetable, a tuber, and a grass.
- the bean is an adzuki, a mung, a pea, a peanut, a lentil, or a garbanzo.
- the leafy vegetable is an alfalfa, an arugula, a mustard, or a Brassica.
- the grass is triticale or spelt.
- the tuber is a potato, a sweet potato, or a cassava.
- the plant has a low polyunsaturated fatty acid content. In some embodiments, the bean or the seed has a low linolenic acid content. In some embodiments, the bean or the seed has a high monounsaturated fatty acid content. In some embodiments, the bean or the seed has a high oleic acid content. In some embodiments, the bean or the seed has a low unsaturated fatty acid content. In some embodiments, the bean or the seed has a high saturated fatty acid content. In some embodiments, the plant has a high monounsaturated fatty acid content and/or a low polyunsaturated fatty acid content. In some embodiments, the plant has a high medium chain fatty acid content. In some embodiments, the plant has a high saturated fatty acid content.
- Figure 1 is a schematic of tetrapyrrole synthesis.
- Figure 2 contains the nucleic acid sequence encoding the Leghemoglobin (Lbc2) from Glycine max (SEQ ID NO:1), the nucleic acid sequence encoding a truncated glutamyl tRNA reductase from Glycine max (corresponding to amino acids 1, and 91 to 542 (end) of Uniprot Q9ZPK4_SOYBN-Glutamyl tRNA reductase) (SEQ ID NO: 2), the nucleic acid sequence encoding the chloroplast ribulose- 1-5 -bisphosphate carboxylase/oxygenase small unit plastid targeting sequence (SEQ ID NO: 3), a nucleic acid sequence encoding a vacuole targeting signal sequence (Conglycinin signal peptide) (SEQ ID NO: 4), a nucleic acid sequence encoding a soluble ferrochelatase from Glycine max (SEQ ID NO: 5, the nucleic acid encodes a polypeptide having
- this document provides methods and materials for making and using transgenic plants to increase the specific biosynthesis of heme for incorporation into heme-containing proteins.
- the heme-containing protein can be produced in the seeds of the transgenic plant to facilitate isolation of the protein.
- transgenic plants with altered fatty acid profiles e.g., high monounsaturated fatty acid (e.g., oleic acid, C18: l) content and/or a low polyunsaturated fatty acid content, a high medium chain fatty acid content, or a high saturated fatty acid content
- polyunsaturated fatty acid content refers to the total amount of linoleic acid (C18:2) and a-linolenic acid (C18:3).
- the total polyunsaturated fatty acid content is low due to a reduction in the a-linolenic acid content. In some embodiments, the total polyunsaturated fatty acid content is low due to a reduction in the linoleic acid content. In some embodiments, the total polyunsaturated fatty acid content is low due to a reduction in both the linoleic acid and a-linolenic acid content. “Medium chain fatty acid content” is used herein to refer to the total amount of caproic acid (C6:0), caprylic acid (C8:0), capric acid (C10:0) and lauric acid (C12:0).
- low polyunsaturated fatty acid content can refer to a polyunsaturated fatty acid content up to 55%, up to 50%, up to 45%, up to 40%, up to 35%, up to 30%, up to 25%, up to 20%, up to 15%, up to 10%, up to 9%, up to 8%, up to 7%, up to 6%, up to 5%, up to 4%, up to 3%, up to 2%, or up to 1%.
- low linolenic acid content can refer to a linolenic acid content of up to 10%, up to 9%, up to 8%, up to 7%, up to 6%, up to 5%, up to 4%, up to 3%, up to 2%, or up to 1%.
- low linoleic acid content can refer to a linoleic acid content of up to 50%, up to 45%, up to 40%, up to 35%, up to 30%, up to 25%, up to 20%, up to 15%, up to 10%, up to 9%, up to 8%, up to 7%, up to 6%, up to 5%, up to 4%, up to 3%, up to 2%, or up to 1%.
- high saturated fatty acid content can refer to a saturated fatty acid content of at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, or at least 80%.
- a high monounsaturated and a low polyunsaturated fatty acid content can refer to a monounsaturated and a polyunsaturated fatty acid content of at least 25% monounsaturated and up to 55% polyunsaturated fatty acid content, at least 30% monounsaturated and up to 50% polyunsaturated fatty acid content, at least 40% monounsaturated and up to 40% polyunsaturated fatty acid content, at least 50% monounsaturated and up to 30% polyunsaturated fatty acid content, at least 60% monounsaturated and up to 20% polyunsaturated fatty acid content, at least 70% monounsaturated and up to 10% polyunsaturated fatty acid content, or at least 80% monounsaturated and up to 5% polyunsaturated fatty acid content.
- a plant, bean, seed, or oil as described herein can have a lower amount (e.g., reduced by at least 5%, 10%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or more) of a polyunsaturated fatty acid content, linolenic acid content, linoleic acid content, unsaturated fatty acid content, or a combination thereof as compared to a corresponding control plant, bean, seed, or oil.
- a lower amount e.g., reduced by at least 5%, 10%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or more
- a plant, bean, seed, or oil as described herein can have a higher amount (e.g., increased by at least 5%, 10%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or more) of a monounsaturated fatty acid, oleic acid content, medium chain fatty acid content, saturated fatty acid content, or a combination thereof as compared to a corresponding control plant, bean, seed, or oil.
- a higher amount e.g., increased by at least 5%, 10%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or more
- plants having a desired fatty acid profile can be used as a source for textured vegetable protein (e.g., textured soy protein) to improve the flavor profile and/or functional characteristics and/or properties of the protein (e.g., one or more of reduced off-flavors, altered gel-strength, altered viscosity, improved oxidative stability, and improved whiteness).
- textured vegetable protein e.g., textured soy protein
- the transgenic plants, cells, and seeds described herein include at least one recombinant nucleic acid that includes a) a promoter operably linked to a nucleic acid encoding a heme-containing polypeptide and b) a promoter operably linked to a nucleic acid that encodes a polypeptide that specifically upregulates heme biosynthesis.
- "Polypeptide” as used herein refers to a compound of two or more subunit amino acids, amino acid analogs, or other peptidomimetics, regardless of post- translational modification, e.g., phosphorylation or glycosylation. The subunits may be linked by peptide bonds or other bonds such as, for example, ester or ether bonds. Full- length polypeptides, truncated polypeptides, point mutants, insertion mutants, inversion mutants, splice variants, chimeric proteins, and fragments thereof are encompassed by this definition.
- one or more of the following polypeptides can be expressed in the transgenic plant: a ferrochelatase, a glutamyl-tRNA reductase (GluTR) binding protein, a truncated glutamate tRNA reductase protein (GTR), or an aminolevulinic acid synthase.
- a transgenic plant may express one, two, three, or four of such polypeptides.
- a transgenic plant may express a ferrochelatase, a ferrochelatase and a GluTR binding protein, a ferrochelatase and a truncated GTR, a ferrochelatase and an aminolevulinic acid synthase, a GluTR binding protein, a GluTR binding protein and a truncated GTR, a GluTR binding protein and an aminolevulinic acid synthase, a truncated GTR, a truncated GTR and an aminolevulinic acid synthase, a ferrochelatase, a GluTR binding protein and a truncated GTR, a ferrochelatase, a GluTR binding protein and an aminolevulinic acid synthase, a GluTR binding protein, a truncated GTR, and an aminolevulinic acid synthase, or a ferrochelatase
- the polypeptide that upregulates heme biosynthesis can be a variant (e.g., comprise a mutation such as an amino acid substitution, e.g., a nonconservative or conservative amino acid substitution, an amino acid deletion, an amino acid insertion, or non-native sequence) relative to a wild-type heme biosynthesis polypeptide.
- a domain such as a transmembrane domain can be removed from a polypeptide that upregulates heme biosynthesis to increase solubility of the polypeptide or a signal peptide can be deleted.
- a ferrochelatase polypeptide can include residues 105 to 531 of the amino acid sequence set forth in Uniprot I1K551 (see SEQ ID NO: 9, Figure 2) or can include residues 105 to 500 and 522 to 531 the amino acid sequence set forth in Uniprot I1K551 (see SEQ ID NO: 9, Figure 2).
- a truncated glutamate tRNA reductase protein can have one or more N- terminal residues (e.g., 5, 10, 15, 20, 25, 30, 35, or 40 residues) removed as described below to, for example, remove feedback inhibition by heme.
- a variant polypeptide can include at most 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 30, 40, or 50 mutations.
- a variant polypeptide comprises at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 30, 40, or 50 or more mutations. In some instances, at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 20, 30, 40, or 50% of the sequence of a polypeptide of the disclosure can be mutated. In some instances, at most 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 20, 30, 40, or 50% of the sequence of a polypeptide can be mutated.
- Ferrochelatase is the enzyme at the branch point of the biosynthetic pathway that pulls the biosynthetic flux towards heme rather than chlorophyll. See, Figure 1.
- Overexpression of a ferrochelatase in combination with a heme protein can increase the heme-loading of the heme polypeptide.
- a ferrochelatase lacking a C-terminal transmembrane domain can be used.
- suitable ferrochelatases include a barley ferrochelatase, a tobacco ferrochelatase, a soy ferrochelatase, a mung bean ferrochelatase (e.g., GenBank Accession No.
- microbial ferrochelatase e.g., a Bradyrhizobium ferrochelatase such as Bradyrhyzobium japonicum ferrochelatase (GenBank Accession No. AJA60352.1) or an Aspergillus ferrochelatase such as Aspergillus niger ferrochelatase.
- microbial ferrochelatase e.g., a Bradyrhizobium ferrochelatase such as Bradyrhyzobium japonicum ferrochelatase (GenBank Accession No. AJA60352.1) or an Aspergillus ferrochelatase such as Aspergillus niger ferrochelatase.
- microbial ferrochelatase e.g., a Bradyrhizobium ferrochelatase such as Bradyrhyzobium japonicum ferrochelatase (GenBank Accession No.
- a GluTR binding protein mediates heme biosynthetic flux through a spatially separated system that leads only to heme and avoids some of the feedback loops. See, for example, Czarnecki et al., J Exp Bot, 63 (4): 1675-1687, 2012.
- suitable GluTR binding proteins include the soy, Arabidopsis thaiHana, barley, Medicago trunculata, adzuki bean, and kidney bean GluTR binding protein. Overexpressing the GluTR binding protein in combination with a heme polypeptide can lead to increased heme-loading of the heme polypeptide.
- Glutamyl tRNA reductase converts glutamate molecules that are ligated to tRNA Glu into glutamate 1 -semialdehyde, an intermediate in the synthesis of 5- aminolevulinate, chlorophyll and heme.
- GluTR activity is inhibited by binding of heme to its N-terminus (see, e.g., Vothknecht et al., Phytochemistry 47: 513-519, 1998). Removal of the first 30 amino acids of a GluTR (e.g., the soy or barley GluTR) removes the feedback inhibition by heme.
- a truncated GluTR protein e.g., a truncated GluTR protein from Glycine max that is 453 amino acids in length, encoded by SEQ ID NO:2
- the optimal truncation may be greater or less than 30 amino acids.
- 5-Aminolevulinic acid a non-protein amino acid
- ALA 5-Aminolevulinic acid
- C4 pathway Shemin pathway
- the C4 pathway is restricted to mammals, fungi and purple nonsulfur bacteria.
- the second route is the C5 pathway, which involves three enzymatic reactions resulting in the biosynthesis of ALA from glutamate.
- the C5 pathway is active in most bacteria, all archaea and plants. See, e.g., Zhang, et al., Sci Rep., 5:8584 (2015).
- bacterial aminolevulinic acid synthase can increase the flux through the tetrapyrrole biosynthesis pathway as plants have no control mechanism for the C4 route of ALA production.
- the increased flux can be captured by the overexpressed heme polypeptide, leading to increased heme-loading of the heme polypeptide.
- the bacterial ALAS can be a Rhodobacter ALAS or rhizobia ALAS such as Bradyrhizobium japonicum ALAS (see SEQ ID NO: 8).
- heme-containing protein can be used interchangeably with “hemecontaining polypeptide” or “heme protein” or “heme polypeptide” or “heme-loaded heme-containing polypeptide” and includes any polypeptide covalently or noncovalently bound to a heme.
- the terms “heme cofactor” and “heme” are used interchangeably and refer to the iron-containing (Fe 2+ or Fe 3+ ) compound of the porphyrin class which forms a nonprotein part of the heme-containing protein.
- the hemecontaining polypeptide is a globin such as one in Pfam 00042 and can include a globin fold, which comprises a series of seven to nine alpha helices.
- Globin type proteins can be of any class (e.g., class I, class II, or class III), and in some embodiments, can transport or store oxygen.
- a heme-containing protein can be a non-symbiotic type of hemoglobin or a leghemoglobin.
- a heme-containing polypeptide can be a monomer, i.e., a single polypeptide chain, or can be a dimer, a trimer, tetramer, and/or higher order oligomer.
- the life-time of the oxygenated Fe 2+ state of a heme-containing protein can be similar to that of myoglobin or can exceed it by 10%, 20%, 30%, 50%, 100% or more under conditions in which the heme-protein-containing consumable is manufactured, stored, handled or prepared for consumption.
- Non-limiting examples of heme-containing polypeptides can include leghemoglobin, an androglobin, a cytoglobin, a globin E, a globin X, a globin Y, a hemoglobin, a myoglobin (e.g., bovine myoglobin), an erythrocruorin, a beta hemoglobin, an alpha hemoglobin, a protoglobin, a cyanoglobin, a cytoglobin, a histoglobin, a neuroglobin, a chlorocruorin, a truncated hemoglobin (e.g., HbN or HbO), a truncated 2/2 globin, a hemoglobin 3 (e.g., Glb3), a cytochrome, or a peroxidase.
- a myoglobin e.g., bovine myoglobin
- an erythrocruorin e.g., bovine
- Heme-containing proteins that can produced in the plants, plant cells, and seeds described herein can be from mammals (e.g., farms animals such as cows, goats, sheep, pigs, ox, or rabbits), birds, plants, algae, fungi (e.g., yeast or filamentous fungi), ciliates, or bacteria.
- a heme-containing protein can be from a mammal such as a farm animal (e.g., a cow, goat, sheep, pig, fish, ox, or rabbit) or a bird such as a turkey or chicken.
- Heme-containing proteins can be from a plant such as Nicotiana tabacum or Nicotiana sylvestris (tobacco); Zea mays (corn), Arabidopsis thaliana, a legume such as Glycine max (soybean), Cicer arietinum (garbanzo or chick pea), Pisum sativum (pea) varieties such as garden peas or sugar snap peas, Phaseolus vulgaris varieties of common beans such as green beans, black beans, navy beans, northern beans, or pinto beans, Vigna unguiculata varieties (cow peas), Vigna radiata (mung beans), Lupinus albus (lupin), or Medicago sativa (alfalfa); Brassica napus (canola); Triticum sps.
- Nicotiana tabacum or Nicotiana sylvestris tobacco
- Zea mays corn
- Arabidopsis thaliana a legume
- a legume such as Glycine max
- Heme-containing proteins can be isolated from fungi such as Saccharomyces cerevisiae. Pichia pasloris. Magnaporthe oryzae, Fusarium graminearum.
- Aspergillus oryzae Trichoderma reesei. Myceliopthera thermophile, Kluyveramyces lactis, o Fusarium oxysporum.
- Heme-containing proteins can be isolated from bacteria such as Escherichia coli, Bacillus subtilis, Bacillus licheniformis, Bacillus megaterium, Synechocistis sp., Aquifex aeolicus, Methylacidiphilum infernorum, or thermophilic bacteria such as Thermophilus spp.
- the sequences and structure of numerous heme-containing proteins are known. See for example, Reedy, et al., Nucleic Acids Research, 2008, Vol.
- a leghemoglobin can be a soy, pea, or cowpea leghemoglobin.
- the heme-containing polypeptide is a flavohemoglobin, a protein composed of a heme binding domain and a ferredoxin reductase-like FAD- and NAD- binding domain. It is also known as flavohemoprotein, nitric oxide dioxygenase, nitric oxide oxygenase and flavodoxin reductase. Flavohemoglobin genes from E. coli, A.
- HMP eutrophus
- FHP FHP
- YHB1 or YHG
- VHP VHP
- a heme-containing polypeptide can be a variant (e.g., comprise a mutation such as an amino acid substitution, e.g., a non-conservative or conservative amino acid substitution, an amino acid deletion, an amino acid insertion, or non-native sequence) relative to a wild-type heme-containing polypeptide.
- a mutation such as an amino acid substitution, e.g., a non-conservative or conservative amino acid substitution, an amino acid deletion, an amino acid insertion, or non-native sequence
- the following command can be used to generate an output file containing a comparison between two nucleic acid sequences: C: ⁇ B12seq -i c: ⁇ seql.txt -j c: ⁇ seq2.txt -p blastp -o c: ⁇ output.txt. If the two compared sequences share homology, then the designated output file will present those regions of homology as aligned sequences. If the two compared sequences do not share homology, then the designated output file will not present aligned sequences.
- the number of matches is determined by counting the number of positions where an identical nucleotide residue is presented in both sequences.
- the percent identity is determined by dividing the number of matches by the length of the full-length nucleic acid sequence followed by multiplying the resulting value by 100. It is noted that the percent identity value is rounded to the nearest tenth. For example, 78.11, 78.12, 78.13, and 78.14 is rounded down to 78.1, while 78.15, 78.16, 78.17, 78.18, and 78.19 is rounded up to 78.2. It also is noted that the length value will always be an integer.
- nucleic acids can encode a polypeptide having a particular amino acid sequence.
- the degeneracy of the genetic code is well known to the art; i.e., for many amino acids, there is more than one nucleotide triplet that serves as the codon for the amino acid.
- codons in the coding sequence for a given enzyme can be modified such that optimal expression in a particular species (e.g., 30 bacteria or fungus) is obtained, using appropriate codon bias tables for that species.
- the transgenic plants, transgenic plant cells, or transgenic seeds contain at least one recombinant nucleic acid that includes a) a promoter operably linked to a nucleic acid encoding a heme-containing polypeptide and b) a promoter operably linked to a nucleic acid that encodes a polypeptide that specifically upregulates heme biosynthesis.
- the promoter operably linked to a nucleic acid encoding the heme-containing polypeptide and the promoter operably linked to a nucleic acid encoding a polypeptide that specifically upregulates heme biosynthesis are on separate nucleic acid constructs.
- the heme-containing polypeptide can be produced in methyl otrophic yeast such as Pichia (e.g., Pichia pastoris). See, for example, U.S. Publication No. 2018/0127764.
- the recombinant nucleic acid is exogenous to the plant, plant cell, or seed.
- exogenous with respect to a nucleic acid indicates that the nucleic acid is not in its natural environment.
- an exogenous nucleic acid can be a sequence from one species introduced into another species, i.e., a heterologous nucleic acid.
- such an exogenous nucleic acid is introduced into the other species via a recombinant nucleic acid construct.
- a heterologous polypeptide as used herein refers to a polypeptide that is not a naturally occurring polypeptide in a plant cell, e.g., a transgenic soybean plant transformed with and expressing the coding sequence for a leghemoglobin from an alfalfa plant.
- the hemecontaining polypeptide being expressed in the plant can be heterologous to the plant.
- the polypeptide that upregulates heme biosynthesis that is being expressed in the plant can be heterologous to the plant.
- An exogenous nucleic acid also can be a sequence that is native to a plant (i.e., it is endogenous to the plant) and that has been reintroduced into cells of that plant such as a nucleic acid encoding a soybean ferrochelatase being re-introduced into a soybean plant.
- the heme-containing polypeptide being expressed in the plant can be endogenous to the plant.
- the polypeptide that upregulates heme biosynthesis that is being expressed in the plant can be endogenous to the plant.
- exogenous nucleic acid that includes a native sequence can often be distinguished from the naturally occurring sequence by the presence of non-natural sequences linked to the exogenous nucleic acid, e.g., non-native regulatory sequences flanking a native sequence in a recombinant nucleic acid construct.
- stably transformed exogenous nucleic acids typically are integrated at positions other than the position where the native sequence is found. It will be appreciated that an exogenous nucleic acid may have been introduced into a progenitor and not into the cell under consideration.
- a transgenic plant containing an exogenous nucleic acid can be the progeny of a cross between a stably transformed plant and a non-transgenic plant.
- Nucleic acid and “polynucleotide” are used interchangeably herein, and refer to both RNA and DNA, including cDNA, genomic DNA, synthetic DNA, and DNA or RNA containing nucleic acid analogs.
- a nucleic acid can be double-stranded or singlestranded (i.e., a sense strand or an antisense strand).
- Non-limiting examples of polynucleotides include genes, gene fragments, exons, introns, messenger RNA (mRNA), transfer RNA, ribosomal RNA, siRNA, micro-RNA, ribozymes, cDNA, recombinant polynucleotides, branched polynucleotides, nucleic acid probes and nucleic acid primers.
- mRNA messenger RNA
- transfer RNA transfer RNA
- ribosomal RNA siRNA
- micro-RNA micro-RNA
- ribozymes cDNA
- recombinant polynucleotides branched polynucleotides
- nucleic acid probes and nucleic acid primers include genes, gene fragments, exons, introns, messenger RNA (mRNA), transfer RNA, ribosomal RNA, siRNA, micro-RNA, ribozymes, cDNA, recombinant polynucleotides, branched polyn
- the promoters can be the same or different, and can vary in strength or tissue-specificity.
- the recombinant nucleic acid construct can be configured such that the nucleic acid encoding the heme-containing polypeptide and the nucleic acid encoding the polypeptide that upregulates heme biosynthesis are contiguous and a single promoter is used to drive transcription of both nucleic acid sequences.
- promoter means a DNA sequence recognized by enzymes/proteins required to initiate the transcription of a specific nucleic acid sequence.
- a promoter typically refers, e.g., to a sequence of nucleic acid to which an RNA polymerase and/or any associated factors binds and at which transcription is initiated.
- the recombinant nucleic includes at least one promoter that is positioned 5’ to the nucleic acid sequence encoding a heme polypeptide or a polypeptide that upregulates heme biosynthesis.
- “operably linked” refers to a segment of DNA being linked to another segment of DNA when placed into a functional relationship with the other segment.
- the promoter can be a seed-specific promoter.
- a seed specific promoter can be from the soy beta-conglycinin gene (see, for example, Chen, et al., Dev Genet., 10(2): 112-22 (1989)) or beta-conglycinin alpha prime subunit 2, a G1 -Glycinin seed specific promoter (Ding, et al.
- a KTI promoter see, for example, Perez-Grau and Goldberg, Plant Cell., 1(11): 1095-1109 (1989)
- an oleosin promoter such as P24
- Other non-limiting examples include promoters from the following seed-genes: zygote and embryo LEC1; suspensor G564; maize MAC1 (see, Sheridan, Genetics 142: 1009-1020 (1996)); maize Cat3, (see, GenBank No. L05934, Abler, Plant Mol. Biol.
- heme-containing polypeptide such as leghemoglobin in seeds
- Producing a heme-containing polypeptide such as leghemoglobin in seeds can be used to facilitate isolation of the protein (e.g., in soluble form).
- the promoter can be a constitutive promoter such as the cauliflower mosaic virus (CaMV) 35S promoter, the mannopine synthase (MAS) promoter, the 1' or 2' promoters derived from T-DNA of Agrobacterium tumefaciens, the figwort mosaic virus 34S promoter, actin promoters such as the rice actin promoter, or a ubiquitin promoter such as the maize ubiquitin-1 promoter. See also U.S. Patent No. 8,115,058 for additional constitutive promoters.
- CaMV cauliflower mosaic virus
- MAS mannopine synthase
- actin promoters such as the rice actin promoter
- a ubiquitin promoter such as the maize ubiquitin-1 promoter. See also U.S. Patent No. 8,115,058 for additional constitutive promoters.
- An inducible promoter can include, for example, a core or basal promoter sequence and one or more elements such as transcriptional activator binding sites or other regulatory element to allow control of transcription.
- a core promoter refers to the minimal sequence necessary for assembly of a transcription complex required for transcription initiation.
- Basal promoters frequently include a "TATA box” element that may be located between about 15 and about 35 nucleotides upstream from the site of transcription initiation.
- Basal promoters also may include a "CCAAT box” element (typically the sequence CCAAT) and/or a GGGCG sequence, which can be located between about 40 and about 200 nucleotides, typically about 60 to about 120 nucleotides, upstream from the transcription start site.
- an inducible promoter can be a modified cauliflower mosaic virus (CaMV) 35S promoter that is responsive to tetracycline. See, Gatz, et al., Plant J. 2, 397- 404 (1992), and Weinmann, et al., Plant J., 5, 559-569 (1994).
- an inducible promoter can be dexamethasone-inducible, or dexamethasone-inducible and tetracycline-inactivatable.
- an inducible promoter can be responsive to copper. See, Mett, et al., Proc. Natl Acad. Set. USA, 90, 4567-4571 (1993).
- an inducible promoter can be ethanol responsive (e.g., ethanol or acetaldehyde). See, Caddick, et al., Nat. Biotechnol., 16, 177-180 (1998); Rosian, et al., Plant J., 28, 225-235 (2001); and Salter, et al., Plant J., 16, 127-132 (1998).
- the Aspergillus nidulans ALCR transcription factor (alcR) drives expression from the palcA promoter by binding to upstream sequences (alcA) from the A. nidulans alcA locus.
- the palcA promoter is positioned upstream of a target DNA for expression.
- the promoter can be a germination specific promoter.
- a promoter results in expression of the target product during germination and/or early seedling growth in one or more of the radical, hypocotyl, cotyledons, epicotyl, root tip, shoot tip, meristematic cells, seed coat, endosperm, true leaves, internodal tissue, and nodal tissue.
- promoters from genes encoding the glyoxysomal enzymes isocitrate lyase (ICL) and malate synthase (MS) from several plant species (Zhang et al., Plant Physiol. 104: 857-864, 1994); Reynolds and Smith, Plant Mol. Biol.
- Promoters also can be from other genes whose mRNAs appear to accumulate specifically during the germination process, for example class I P-l,3-glucanase B from tobacco (Vogeli-Lange et al, Plant J., 5: 273-278, 1994); canola cDNAs CA25, CA8, AX92 (Harada et al., Mol. Gen. Genet., 212: 466-473, 1988); Dietrich et al., J.
- lipid transfer protein Sossountzove et al, Plant Cell, 3: 923-933, 1991
- rice serine carboxypeptidases Wango et al., Plant Phys., 105: 1275-1280, 1994
- repetitive proline rich cell wall protein genes Datta et al., Plant Mol. Biol. 14: 285-286, 1990.
- the a-amylase promoter also can be used as a germination specific promoter. See, Eskelin, et al., Plant Biotechnology Journal, 7: 657-672 (2009).
- promotors can include aleurone-specific promoters, endosperm-specific promoters, embryo-specific promoters, leaf-and-stem-specific promoters, panicle-specific promoters, root-specific promoters, and pollen-specific promoters (see, for example U.S. Patent No. 8,115,058).
- the nucleic acid construct further includes a targeting sequence that can be used to direct the heme polypeptide and/or heme biosynthesis polypeptide to one of several different intracellular compartments, including, for example, the endoplasmic reticulum (ER), mitochondria, plastids (such as chloroplasts) such as the RuBisCo plastid targeting sequence, the vacuole, the Golgi apparatus, protein storage vesicles (PSV) and, in general, membranes, to structures such as the roots, or cells in, for example, the hypocotyl.
- the heme polypeptide and/or heme biosynthesis polypeptide can be directed to the same intracellular location or to different intracellular locations.
- a chloroplast targeting sequence can be a pea, rice, tobacco, Arabidopsis, or soy rubisco small subunit (rbcS) transit peptide (Van den Broeck, et al., Nature, 313, 358-363, 1985).
- rbcS rubisco small subunit
- a portion of the N-terminal unfolded region (e.g., 18, 19, 20, 21, 22, 23, 24, or 25 amino acids) of the rbcS protein can be included in the chloroplast target sequence (see, e.g., Shen, et al., 2017, supra), for a total length of 50- 80 amino acids (e.g., 60, 65, 70, 75 amino acids).
- some targeting peptides are bipartite, directing proteins first to an organelle and then to a membrane within the organelle (e.g. within the thylakoid lumen of the chloroplast; see Keegstra and Cline, 1999, supra).
- placement of the signal peptide is also varied. Proteins destined for the vacuole, for example, can have targeting signal peptides found at the N-terminus, at the C-terminus and at a surface location in mature, folded proteins.
- a nucleic acid construct includes a root targeting sequence such as domain A of the CaMV 35S promoter (e.g., containing a tandem repeat of the sequence TGACG separated by 7 base pairs). See, for example, Benfey, et al., The EMBO Journal, 8(8):2195-2202, 1989.
- a nucleic acid sequence encoding a soy conglycinin vacuole targeting signal peptide, a soy glycinin vacuole targeting signal peptide, or a plant seed storage protein vacuole targeting signal peptide is used as a targeting sequence.
- heme-containing polypeptides can be produced in methylotrophic yeast such as Pichia (e.g., Pichia pastoris) or in transgenic plants, transgenic cells, or transgenic seeds using inducible promoters and/or the positive feedback loop disclosed in U.S. Publication No. 2018/0127764.
- methylotrophic yeast such as Pichia (e.g., Pichia pastoris)
- transgenic plants, transgenic cells, or transgenic seeds using inducible promoters and/or the positive feedback loop disclosed in U.S. Publication No. 2018/0127764.
- Transgenic plant cells and plants comprising at least one recombinant nucleic acid construct described herein can be produced using a variety of techniques. For example, Agrobaclerium-m dx&i transformation, viral vector-mediated transformation, electroporation, or particle gun transformation can be used for introducing nucleic acids into monocotyledonous or dicotyledonous plants. See, for example, U.S. Patent Nos. 5,538,880; 5,204,253; 6,329,571 and 6,013,863.
- gene editing techniques using site-specific nucleases, zinc finger nucleases, transcription activator-like effector nucleases (TALENS), or the clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9 system can be used to produce plants or cells having altered characteristics including one or more of fatty acid profile, flavor profile, or sugar content. See, for example, Aroroa and Narula, Front. Plant Sc. 8: 1932 (2017). If a cell or cultured tissue is used as the recipient tissue for transformation, plants can be regenerated from transformed cultures if desired, by techniques known to those skilled in the art.
- the inverted DNA fragment is about 2Mb to about 4Mb, about 3Mb to about 5Mb, about 4Mb to about 6Mb, about 3Mb to about 4Mb, about 3.5Mb to about 4.5Mb, or about 4Mb to about 5Mb in length.
- a site-specific nuclease can be used to cleave between the signal peptide sequence and the coding region sequence of the nucleic acid encoding a seedstorage polypeptide, such that the seed-specific promoter is linked to the signal peptide sequence, and a second site-specific nuclease can be used to cleave between the promoter of a nucleic acid encoding a heme-containing polypeptide and the nucleic acid encoding the heme-containing polypeptide.
- Site-specific cleavage can produce a fragment of DNA that can be naturally inverted before repair with, for example, host repair enzymes, such that the nucleic acid encoding the heme-containing polypeptide is operably linked to the seed-specific promoter and signal peptide sequence of the nucleic acid encoding the seedstorage polypeptide.
- Seed-storage polypeptides can include, but are not limited to, beta- conglycinin alpha prime subunit 2.
- Heme-containing polypeptides can include, but are not limited to, leghemoglobin C2 (lbc2).
- Oryza sativa rice
- Glycine max or Glycine soja a beet
- a sugar beet parsnip
- a sunflower a bean
- a bean such as an adzuki, a mung, a pea, a peanut, a lentil, or a garbanzo
- a leafy vegetable such as an alfalfa, an arugula, a mustard, or a Brassica
- a grass such as a barley, an oat, a wheat, a corn, a rye, triticale, or spelt.
- Suitable soybean plants can produce seeds of any color, including black, brown, red, yellow, or green, and can be variegated or bicolored.
- the color of a seed or a bean can be influenced by a target protein (e.g., a heme-containing protein) and/or environmental conditions (e.g., temperature and/or pH).
- a soy plant can be used that produces an oil with a high saturated fatty acid content.
- a soy plant can be used that produces an oil with a high saturated fatty acid content.
- soy plants that produce an oil with 40% or more stearic acid (e.g., 50% stearic acid).
- U.S. Publication No. 2004/0049813 describes soy plants that produce an oil with a combined palmitic acid and stearic acid content of greater than 21%, an oleic acid content of greater than 60% and a polyunsaturated fatty acid content of less than 7%.
- a soy plant can be used that has a higher protein content.
- International Publication No. WO 2020/106488 describes a soy plant with decreased expression or activity of one or more HECT E3 ligases (HEL) that has an increased protein content.
- HELI HECT E3 ligases
- knocking out HELI, or both HELI and HEL2 increased seed protein content significantly compared to wild type plants, and knocking out both HELI and HEL2 showed higher seed protein content than the HELI knockout.
- the knockout of HELI showed increased oleic and stearic acid contents and reduced linolenic, palmitic and stachyose contents.
- Knockout of both HELI and HEL2 increased oleic content and reduced linoleic, linolenic, palmitic, stearic, stachyose, and total soluble carbohydrate contents.
- the fatty acid profile of a plant can be modified by breeding or genetic engineering. See, for example, Nguyen, et al., Curr Genomics, 17(3):241-260 (2016), Clemente and Cahoon, Plant Physiol., 151(3): 1030-1040 (2009), and U.S. Patent No. 6,323,392.
- a plant can have decreased activity of delta- 12 desaturase, which converts oleic acid to linoleic acid.
- the plants can be modified such that they contain increased oleoyl- or stearoyl-ACP thioesterase activity and decreased fatty acid desaturase activities, including delta-9, delta-12, and delta-15 desaturase activities.
- Plants also can be modified such that they contain increased 3 -ketoacyl -ACP synthase II (KAS II). Increased thioesterase activity may not be necessary if delta-9 desaturase activity is completely inhibited. Plants also can exhibit increased palmitoyl-ACP thioesterase activity.
- the expression and/or activity of one or more enzymes that act on lipids or fatty acids in a plant can be modified by breeding or genetic engineering.
- lipases hydrolyze lipids into free fatty acids, which can generate off-flavors upon oxidation.
- Lipoxygenases such as 9-lipoxygenases or 13 -lipoxygenases, catalyze the dioxygenation of polyunsaturated fatty acids, such as linoleic acid, alpha-linolenic acid, or arachidonic acid, into hydroperoxides.
- plants can have a desired fatty acid profile (e.g., a high monounsaturated fatty acid content and/or a low polyunsaturated fatty acid content, a high medium chain fatty acid content, or a high saturated fatty acid content) and decreased expression and/or activity of one or more lipases, lipoxygenases, and/or hydroperoxide lyases.
- a desired fatty acid profile e.g., a high monounsaturated fatty acid content and/or a low polyunsaturated fatty acid content, a high medium chain fatty acid content, or a high saturated fatty acid content
- a plant, bean, or seed as described herein can have a lower expression and/or activity (e.g., reduced by at least 5%, 10%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or more) of a lipase, lipoxygenase, hydroperoxide lyase, or a combination thereof as compared to a corresponding control plant, bean, or seed.
- a low lipase, lipoxygenase, and/or hydroperoxide lyase activity can yield a low flavor plant (and/or protein product produced therefrom). See, for example International Publication No. WO 2017/218883.
- hybrids of plants with modified FAD-2 or FAD-3 enzymes can result in altered fatty acid profiles.
- a hybrid between a female Brassica napus parent with a homozygous modified FAD-2 (delta- 12 fatty acid desaturase 2) in either A- or C-genome and a male Brassica napus plant with a homozygous modified FAD-2 in both the A- and C-genomes can result in progeny that produce elevated oleic acid (C18: l) of at least 80% by weight and reduced linolenic acid (C18:3) content of no more than 3% by weight of total fatty acid content in their seeds. See, for example, U.S. Patent No. 6,323,392.
- oleic acid content of seeds is increased to between 70% and 90% and linolenic acid content is decreased to less than about 3% by weight of the total fatty acids in the seed of a plant (e.g., a soybean, canola, or sunflower plant) with four or more modifications to the genes encoding a FAD2 and a FAD3 polypeptide, such as FAD2-1 A, FAD2-1B, FAD3a, and FAD3b compared to the seed of a corresponding control plant without the introduced genetic modifications.
- a plant e.g., a soybean, canola, or sunflower plant
- a thioesterase e.g., the Umbellularia californica Nutt. FATB1
- medium-chains fatty acids such as C12:0 and C14:0 from the plastid fatty acid synthetic pathway
- a plant e.g., a soy plant. See, for example, Hu, et al.. PLosS One, 12(2):e0172296 (2017), and Voelker, et al., Science, 257(5066):72-4 (1992).
- plants having a desired fatty acid profile can be used as a source for textured vegetable protein (e.g., textured soy protein) to improve the flavor profile and/or functional characteristics of the protein (e.g., one or more of reduced off-flavors, altered gel-strength, altered viscosity, improved oxidative stability, and improved whiteness).
- textured vegetable protein e.g., textured soy protein
- Methods for making textured vegetable protein (e.g., textured soy protein) having reduced off-flavors can include isolating protein from soybeans that yield an oil having a high monounsaturated fatty acid content and/or a low polyunsaturated fatty acid content and processing the soy protein to obtain textured soy protein (e.g., forming the soy protein into desired shape by extrusion, or cooking the soy protein and spray drying).
- a plant has a low polyunsaturated fatty acid (e.g., linolenic acid and/or linoleic acid) content. In some embodiments, a plant has a low linolenic acid content. In some embodiments, a plant has a high monounsaturated fatty acid content. In some embodiments, a plant has a high oleic acid content. In some embodiments, a plant has a low polyunsaturated fatty acid content and a high monounsaturated fatty acid content. In some embodiments, a plant has a low linolenic acid content and a high oleic acid content.
- a plant has a low polyunsaturated fatty acid content and a high oleic acid content. In some embodiments, a plant has a low linolenic acid content and a high monounsaturated fatty acid content. In some embodiments, a plant has a low unsaturated fatty acid content. In some embodiments, a plant has a high saturated fatty acid content. Without being bound by any particular theory, it is believed that in some embodiments, a low linolenic acid content can yield a low flavor plant (and/or protein product produced therefrom).
- Having less flavor can be determined, for example, by a trained human panelist, or, for example, by measurement of one or more volatile compounds commonly understood to impart flavor and/or aroma.
- a different fatty acid may be increased, for example, a saturated fatty acid, such as stearic acid or palmitic acid, or a combination of one or more saturated fatty acids.
- a transformed cell, callus, tissue, or plant can be identified and isolated by selecting or screening the engineered plant material for particular polypeptides or activities, e.g., those encoded by marker genes or antibiotic resistance genes. Such screening and selection methodologies are well known to those having ordinary skill in the art. In addition, physical and biochemical methods can be used to identify transformants.
- RNA transcripts include Southern analysis or PCR amplification for detection of a polynucleotide; Northern blots, SI RNase protection, primer-extension, quantitative realtime PCR, or reverse transcriptase PCR (RT-PCR) amplification for detecting RNA transcripts; enzymatic assays for detecting enzyme or ribozyme activity of polypeptides and polynucleotides; and protein gel electrophoresis, Western blots, immunoprecipitation, and enzyme-linked immunoassays to detect polypeptides.
- Other techniques such as in situ hybridization, enzyme staining, and immunostaining also can be used to detect the presence or expression of polypeptides and/or polynucleotides.
- a polynucleotide After a polynucleotide is stably incorporated into a transgenic plant, it can be introduced into other plants using, for example, standard breeding techniques. A population of transgenic plants can be screened and/or selected for those members of the population that produce the target product. For example, a population of progeny of a single transformation event can be screened for those plants having a desired level of expression of the target polypeptide or nucleic acid encoding the target polypeptide.
- a plant or plant cell can be transformed by having a construct integrated into its genome, i.e., can be stably transformed.
- Stably transformed cells typically retain the introduced nucleic acid with each cell division.
- a plant or plant cell also can be transiently transformed such that the construct is not integrated into its genome.
- Transiently transformed cells typically lose all or some portion of the introduced nucleic acid construct with each cell division such that the introduced nucleic acid cannot be detected in daughter cells after a sufficient number of cell divisions. Both transiently transformed and stably transformed transgenic plants and plant cells can be useful in the methods described herein.
- Transgenic plant cells used in methods described herein can constitute part or all of a whole plant. Such plants can be grown in a manner suitable for the species under consideration, either in a growth chamber, a greenhouse, or in a field. Transgenic plants can be bred as desired for a particular purpose, e.g., to introduce a recombinant nucleic acid into other lines, to transfer a recombinant nucleic acid to other species, or for further selection of other desirable traits. Alternatively, transgenic plants can be propagated vegetatively for those species amenable to such techniques. As used herein, a transgenic plant also refers to progeny of an initial transgenic plant provided the progeny inherits the transgene.
- a transgenic plant also refers to progeny of an initial transgenic plant provided the progeny inherits the transgene.
- Progeny includes descendants of a particular plant or plant line.
- Progeny of an instant plant include seeds formed on Fi, F2, F3, F4, F5, Fe and subsequent generation plants, or seeds formed on BCi, BC2, BC3, and subsequent generation plants, or seeds formed on F1BC1, F1BC2, F1BC3, and subsequent generation plants.
- the designation Fi refers to the progeny of a cross between two parents that are genetically distinct.
- the designations F2, F3, F4, F5, and Fe refer to subsequent generations of self- or sib-pollinated progeny of an Fi plant. Seeds produced by a transgenic plant can be grown and then selfed (or outcrossed and selfed) to obtain seeds homozygous for the nucleic acid construct.
- the transgenic plants or plant cells described herein can be grown in a manner suitable for the species under consideration, either in a growth chamber, a greenhouse, or in a field, and then the heme-loaded polypeptide can be isolated.
- the heme-loading of recombinant heme-containing polypeptides can be increased using the methods and transgenic plants, cells, and seeds described herein.
- overall heme-loaded heme protein concentration can be increased in the transgenic plants, cells, and seeds described herein.
- increased heme loading caused by the upregulation of heme biosynthesis can increase overall heme-loaded protein accumulation in the transgenic plants, cells, and seeds described herein.
- increased heme biosynthesis allows the accumulation of more heme-loaded protein than a corresponding control plant.
- a “corresponding control plant” is a similar plant except lacking the transgene or not expressing the transgene.
- a corresponding control plant of a transgenic plant that has a gene encoding a heme-containing polypeptide expressed in seeds would be the same in all aspects (e.g., genetic makeup of plant and so forth), except that the transgenic plant would express a heme-containing polypeptide in the seeds that the corresponding control plant does not.
- the heme-loaded hemecontaining polypeptide can be present in one or more plant tissues, e.g., seeds, vegetative tissues, reproductive tissues, or root tissues, at increased levels relative to that of corresponding control plants that do not express the polypeptide that upregulates heme biosynthesis.
- plant tissues e.g., seeds, vegetative tissues, reproductive tissues, or root tissues
- the heme-loading of a recombinant heme-containing polypeptide can be increased by at least 2 percent, e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 25, 30, 35, 40, 45, 50, 55, 60, or more than 60 percent, as compared to the heme-loading of the heme-containing polypeptide in a corresponding control plant that does not express the polypeptide that upregulates heme biosynthesis.
- the heme loaded heme-containing polypeptide can be at least 0.01%, 0.05%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10% or more of total seed protein in seeds of the transgenic plant.
- the heme loaded hemecontaining polypeptide can be at least 0.01%, 0.05%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10% or more of total protein from other plant tissues (e.g., roots, leaves, etc.).
- the transgenic seeds can be germinated in a contained system in the presence of an inducer and the heme-loaded polypeptide can be isolated from the seedlings.
- a “contained system” refers to a system for germinating transgenic seeds in bulk in a controlled environment (e.g., controlled temperature, light, moisture, fertilizer, and/or humidity) such as a malting or hydroponic system. Germinating seeds in a greenhouse or under field conditions is not considered to be a contained system. See, for example, U.S. Publication No. 2019/0292555 and International Publication No. WO 2018/102656.
- Heme-loaded proteins also can be separated on the basis of their solubility, for example, by ammonium sulfate precipitation, isoelectric precipitation, surfactants, detergents or solvent extraction. Heme-loaded proteins also can be separated by their affinity to another molecule, using, for example, hydrophobic interaction chromatography, reactive dyes, or hydroxyapatite. Isoelectric points of target proteins, such as heme-loaded proteins, can be modified by altering the charge exposed amino acid residues to facilitate separation (see, for example, U.S. Patent No. 9,828,429).
- heme loaded proteins can be extracted in native form as described in WO 2016/054375.
- a heme-loaded protein can be extracted from the processed plant material with an aqueous solution containing polyethylene glycol (PEG) (e.g., PEG having a MW of 8000) and, optionally, a flocculant such as an alkylamine epichlorohydrin, to generate an extraction slurry that contains bulk solids and an extract; optionally adjusting the pH of the extraction slurry to a pH of 2 to 10; collecting the extract and adding salt such as magnesium sulfate to form a two-phase mixture, separating the two-phase mixture using, for example, gravity settling or centrifugation (e.g., using a disk stack centrifuge) to generate a PEG phase and a product phase; and collecting and filtering (e.g., microfiltering) the product phase to generate a filtered product phase that contains the protein.
- PEG polyethylene glycol
- a flocculant
- the filtered product phase can be concentrated and diafiltered to generate a target product concentrate.
- a product concentrate can be sterilized, e.g., by UV irradiation, pasteurization, or microfiltration, and dried, e.g., by spray drying or a freeze drying under mild conditions.
- methods of preparing a protein composition can include (a) adding an aqueous solution to a source protein composition (e.g., a protein composition from plants, cells, seeds, or other plant parts, or from bacteria, fungi) to form a solution of solubilized protein; (b) optionally removing solids from the solution of solubilized protein; (c) adding an organic solvent (e.g., methanol or ethanol) to the solution of solubilized protein to form a solid phase and a liquid phase, and (d) separating the solid phase from the liquid phase to form a protein composition.
- a source protein composition e.g., a protein composition from plants, cells, seeds, or other plant parts, or from bacteria, fungi
- an organic solvent e.g., methanol or ethanol
- methods for purifying the protein minimize the development of undesirable odors and flavors in the purified protein, enhance functionality and increase protein yield.
- Such methods can include, for example, lysing an aqueous suspension of a plurality of cells to obtain a cell lysate; clarifying the cell lysate, optionally in the presence of one or more flocculants, to obtain a clarified lysate; filtering the clarified lysate to obtain a filtered lysate; concentrating the filtered lysate to obtain a protein composition; and optionally pasteurizing the protein composition of protein to obtain a pasteurized protein composition, wherein the lysing, clarifying, and filtering steps, independently, are performed at a pH between about 8.5 and about 12.0.
- the method optionally can include any one or more of the following: filtering (e.g., microfiltration, ultrafiltration, diafiltration, or a combination thereof), clarifying (e.g., by centrifugation to less than about 20% dry solids), or washing an aqueous suspension of a plurality of cells at a pH between about 8.5 and about 12.0 before step a).
- filtering e.g., microfiltration, ultrafiltration, diafiltration, or a combination thereof
- clarifying e.g., by centrifugation to less than about 20% dry solids
- washing an aqueous suspension of a plurality of cells at a pH between about 8.5 and about 12.0 before step a.
- the method including: a) perforating the cell walls of the plurality of cells, b) separating an aqueous suspension of the plurality of cells to form a solids portion and a liquid portion, c) filtering the liquid portion to form a filtrate and a retentate, d) concentrating the retentate to form a protein composition, and e) optionally pasteurizing the protein composition, wherein each of a)-d), independently, are performed at a pH of about 8.5 and about 12.0, and/or wherein the method results in the liquid portion including at least about 50% by weight of the cytoplasmic proteins of the plurality of cells. See, for example, PCT/US2020/050774, entitled “Protein Methods and Compositions” and filed September 14, 2020.
- Additional methods for producing protein compositions can include an extraction using a mixture of supercritical carbon dioxide, and optionally an organic solvent (see, for example, U.S. Patent No. 7,638,155 and U.S. Publication No. 2008/0145511), salting-out methods, using, for example, ammonium sulfate fractionation of phospholipid-bound proteins, or cyclodextrin, for example P-cyclodextrin, treatment methods than can optionally include physicochemical treatments (see, for example, Damogna and Arora, Annu. Rev. Food Sci. Technol. 2013. 4:327-346).
- This document also relates to food products that include proteins produced and/or purified as described herein (e.g., plant-based food compositions such as plant-based meat substitutes like plant-based chicken or beef substitutes).
- plant-based food compositions such as plant-based meat substitutes like plant-based chicken or beef substitutes.
- Exemplary food products are described in, for example, U.S. Publication Numbers 20140193547(Al) and 20150305361(Al), and U.S. Patent Nos. 10,039,306; 9,700,067; 10,172,380; and 9,011,949.
- plants having a desired fatty acid profile e.g., a high monounsaturated fatty acid content and/or a low polyunsaturated fatty acid content
- Plenish® soybeans U.S. Publication No.
- a high medium chain fatty acid content or a high saturated fatty acid content
- other desired characteristics e.g., pea cultivar Snak Hero (SL3192), optionally with modified fatty acid metabolism (see, for example, U.S. Patent No. 10,660,297)
- textured vegetable protein e.g., textured soy protein
- other protein products e.g., protein concentrate or protein isolate
- the flavor profile and/or functional characteristics of the protein e.g., one or more of reduced off-flavors, altered gelstrength, altered viscosity, improved oxidative stability, and improved whiteness
- Methods for making textured vegetable protein (e.g., textured soy protein) having reduced off-flavors can include isolating protein from soybeans that yield an oil having a high monounsaturated fatty acid content and/or a low polyunsaturated fatty acid content and processing the soy protein to obtain textured soy protein (e.g., forming the soy protein into desired shape by extrusion, or cooking the soy protein and spray drying).
- the proteins are prepared by aqueous ethanol extraction, subjected to an initial heating and holding process to re-solubilize the proteins, and optionally an enzyme hydrolysis to further modify and functionalize the proteins. Protein isolates prepared in such a manner have very low fat content and are bland tasting and have low levels of volatile compounds. See, e.g., U.S. Publication No. 2008/0008815.
- plants having a desired fatty acid profile can be used as a source for lipids (including, but not limited to, oils, fats, phospholipids, triglycerides, diglycerides, monoglycerides, and free fatty acids) with a desired profile.
- lipids can be purified separately from proteins, for example, by trapping lipids in lipid bodies and isolating the lipid bodies.
- food products e.g., plant-based food compositions such as plant-based meat substitutes like plant-based chicken or beef substitutes
- a desired fatty acid profile e.g., a high monounsaturated fatty acid content and/or a low polyunsaturated fatty acid content, a high medium chain fatty acid content, or a high saturated fatty acid content
- food products are configured for consumption by humans.
- food products may include one or more of metal ions or minerals (e.g., sodium, potassium, calcium, magnesium), organic acids (e.g., acetic acid, ascorbic acid, citric acid, folic acid, fumaric acid, glycolic acid, lactic acid, malic acid, succinic acid, tartaric acid), free amino acids (e.g., cysteine, methionine, isoleucine, leucine, lysine, phenylalanine, threonine, tryptophan, valine, arginine, histidine, alanine, asparagine, aspartate, glutamate, glutamine, glycine, proline, serine, tyrosine, selenocysteine, citrulline, ornithine, beta-alanine, homoserine, non- proteinogenic amino acid, amino acid
- metal ions or minerals e.g., sodium, potassium, calcium, magnesium
- organic acids e.g., acetic acid
- food products can contain one or more heme-containing polypeptides.
- food products may be free of one or more ingredients selected from gluten (e.g., wheat gluten), wheat-derived allergens, peanut-derived allergens, tree-nut-derived allergens, milk-derived allergens, egg-derived allergens, shellfish-derived allergens, fish-derived allergens, soy-derived allergens, sesame-derived allergens, caramel coloring, artificial coloring, artificial flavors, artificial sweeteners, high-fructose corn syrup, sugar alcohols, cholesterol, trans fats, hydrogenated oils, nitrites, and nitrates, among other ingredients.
- food products may be free of heme-containing polypeptides from an animal source. In some embodiments, food products may be free of animal products.
- plant-based food compositions such as plant-based meat substitutes like plant-based chicken or beef substitutes may contain one or more ingredients derived from algae, fungi (e.g., yeast or filamentous fungi), ciliates, and/or bacteria, such as proteins, lipids, hydrolysates, or extracts.
- a target protein other than a heme-containing protein can be used, such as a protein that modifies other proteins (e.g., a glutaminase).
- a target protein can include one or more enzymes in the biosynthetic pathway of a molecule of interest (e.g., a pharmaceutical (e.g., a polyketide), a porphyrin or derivative thereof (e.g., a heme), or a carbohydrate (e.g., methylcellulose)).
- a “pharmaceutical” can be any compound and/or composition useful for preventing, treating, or ameliorating a disease or a symptom thereof.
- a pharmaceutical can include a protein (e.g., an antibody or antigen-binding fragment thereof or a therapeutic enzyme, such as an 1-asparaginase).
- a pharmaceutical can include an organic and/or inorganic compound (e.g., a polyketide such as erythromycin).
Abstract
La présente invention concerne de manière générale des plantes transgéniques qui expriment de manière recombinante des séquences d'acide nucléique codant pour des polypeptides capables de réguler à la hausse la biosynthèse de l'hème, les plantes ayant un profil d'acides gras modifié, et des procédés de production de polypeptides d'hème chargés d'hème.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063087146P | 2020-10-02 | 2020-10-02 | |
US63/087,146 | 2020-10-02 | ||
US202163180849P | 2021-04-28 | 2021-04-28 | |
US63/180,849 | 2021-04-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2022072846A2 true WO2022072846A2 (fr) | 2022-04-07 |
WO2022072846A3 WO2022072846A3 (fr) | 2022-05-05 |
Family
ID=78463939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2021/053199 WO2022072846A2 (fr) | 2020-10-02 | 2021-10-01 | Plantes transgéniques ayant des profils d'acides gras modifiés et une biosynthèse d'hème régulée à la hausse |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2022072846A2 (fr) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11359206B2 (en) | 2020-10-28 | 2022-06-14 | Pioneer Hi-Bred International, Inc. | Leghemoglobin in soybean |
US11401526B2 (en) | 2020-09-30 | 2022-08-02 | Nobell Foods, Inc. | Recombinant fusion proteins for producing milk proteins in plants |
CN114874929A (zh) * | 2022-06-10 | 2022-08-09 | 江南大学 | 一种高效合成血红素的毕赤酵母重组菌株的构建 |
US11840717B2 (en) | 2020-09-30 | 2023-12-12 | Nobell Foods, Inc. | Host cells comprising a recombinant casein protein and a recombinant kinase protein |
WO2024003668A1 (fr) | 2022-06-29 | 2024-01-04 | Moolec Science Limited | Expression élevée de protéine héminique animale dans des plantes |
Citations (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5204253A (en) | 1990-05-29 | 1993-04-20 | E. I. Du Pont De Nemours And Company | Method and apparatus for introducing biological substances into living cells |
US5538880A (en) | 1990-01-22 | 1996-07-23 | Dekalb Genetics Corporation | Method for preparing fertile transgenic corn plants |
US5981781A (en) | 1996-04-26 | 1999-11-09 | E. I. Du Pont De Nemours And Company | Soybean oil having high oxidative stability |
US6013863A (en) | 1990-01-22 | 2000-01-11 | Dekalb Genetics Corporation | Fertile transgenic corn plants |
US6323392B1 (en) | 1999-03-01 | 2001-11-27 | Pioneer Hi-Bred International, Inc. | Formation of brassica napus F1 hybrid seeds which exhibit a highly elevated oleic acid content and a reduced linolenic acid content in the endogenously formed oil of the seeds |
US6329571B1 (en) | 1996-10-22 | 2001-12-11 | Japan Tobacco, Inc. | Method for transforming indica rice |
US6365802B2 (en) | 1998-08-14 | 2002-04-02 | Calgene Llc | Methods for increasing stearate content in soybean oil |
US20040049813A1 (en) | 1998-05-11 | 2004-03-11 | Russell Booth John | Novel gene combinations that alter the quality and functionality of soybean oil |
US20040216189A1 (en) | 2001-01-09 | 2004-10-28 | Nancy Houmard | Maize chloroplast aldolase promoter compositions and methods for use thereof |
WO2006121757A2 (fr) | 2005-05-05 | 2006-11-16 | Monsanto Technology, Llc | Plantes contenant un gene de flavohemoglobine heterologue et procedes d'utilisation desdites plantes |
US20080008815A1 (en) | 2006-06-21 | 2008-01-10 | Cho Myong J | Bland tasting soy protein isolate and processes for making same |
US20080145511A1 (en) | 2005-06-23 | 2008-06-19 | Solae, Llc | Soy protein products having reduced off-flavor and processes for making the same |
US20080312082A1 (en) | 2006-10-31 | 2008-12-18 | Kinney Anthony J | Soybean event dp-305423-1 and compositions and methods for the identification and/or detection thereof |
US8115058B2 (en) | 2001-09-26 | 2012-02-14 | Syngenta Participations Ag | Rice promoters for regulation of plant expression |
US20140193547A1 (en) | 2011-07-12 | 2014-07-10 | Maraxi, Inc. | Methods and compositions for consumables |
WO2015038796A2 (fr) | 2013-09-11 | 2015-03-19 | Impossible Foods Inc. | Sécrétion de polypeptides contenant un hème |
US9011949B2 (en) | 2011-07-12 | 2015-04-21 | Impossible Foods Inc. | Methods and compositions for consumables |
US20150305361A1 (en) | 2013-01-11 | 2015-10-29 | Impossible Foods Inc. | Methods and compositions for consumables |
US20160024512A1 (en) | 2001-07-06 | 2016-01-28 | Monsanto Technology Llc | Methods For Enhancing Segregation of Transgenes in Plants and Compositions Thereof |
WO2016054375A1 (fr) | 2014-10-01 | 2016-04-07 | Impossible Foods Inc. | Procédés d'extraction et de purification de protéines non dénaturées |
US20160340411A1 (en) | 2013-01-11 | 2016-11-24 | Impossible Foods Inc. | Secretion of heme-containing polypeptides |
US9700067B2 (en) | 2011-07-12 | 2017-07-11 | Impossible Foods Inc. | Methods and compositions for affecting the flavor and aroma profile of consumables |
US9828429B2 (en) | 2007-09-26 | 2017-11-28 | Chugai Seiyaku Kabushiki Kaisha | Method of modifying isoelectric point of antibody via amino acid substitution in CDR |
WO2017218883A1 (fr) | 2016-06-17 | 2017-12-21 | Arcadia Biosciences, Inc. | Végétaux à activité de la lipase 1 réduite |
US9918485B2 (en) | 2007-12-21 | 2018-03-20 | E I Du Pont De Nemours And Company | Soy protein products having altered characteristics |
US20180127764A1 (en) | 2015-05-11 | 2018-05-10 | Impossible Foods Inc. | Expression constructs and methods of genetically engineering methylotrophic yeast |
WO2018102721A1 (fr) | 2016-12-02 | 2018-06-07 | City Of Hope | Plantes transgéniques à biosynthèse d'hème régulée à la hausse |
WO2018102656A1 (fr) | 2016-12-02 | 2018-06-07 | City Of Hope | Production de produits recombinés dans des systèmes contenus |
US10039306B2 (en) | 2012-03-16 | 2018-08-07 | Impossible Foods Inc. | Methods and compositions for consumables |
US10172380B2 (en) | 2014-03-31 | 2019-01-08 | Impossible Foods Inc. | Ground meat replicas |
WO2019173125A1 (fr) | 2018-03-09 | 2019-09-12 | Pioneer Hi-Bred International, Inc. | Compositions et procédés de modification d'acides gras du soja |
US10660297B1 (en) | 2019-10-22 | 2020-05-26 | Syngenta Crop Protection Ag | Pea variety Snak Hero |
WO2020106488A1 (fr) | 2018-11-19 | 2020-05-28 | Pioneer Hi-Bred International, Inc. | Gène de soja et son utilisation pour modifier une composition de graine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5959187A (en) * | 1996-09-26 | 1999-09-28 | Bailey; James E. | Expression of oxygen-binding proteins in plants |
EP1285965A1 (fr) * | 2001-08-06 | 2003-02-26 | Meristem Therapeutics | Boíte endosperme biafactorielle, facteur de trans-activation qui s'y fixe, et méthode de régulation de l'activité d'un promoteur |
US7790953B2 (en) * | 2006-03-10 | 2010-09-07 | Monsanto Technology Llc | Soybean seed and oil compositions and methods of making same |
-
2021
- 2021-10-01 WO PCT/US2021/053199 patent/WO2022072846A2/fr active Application Filing
Patent Citations (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5538880A (en) | 1990-01-22 | 1996-07-23 | Dekalb Genetics Corporation | Method for preparing fertile transgenic corn plants |
US6013863A (en) | 1990-01-22 | 2000-01-11 | Dekalb Genetics Corporation | Fertile transgenic corn plants |
US5204253A (en) | 1990-05-29 | 1993-04-20 | E. I. Du Pont De Nemours And Company | Method and apparatus for introducing biological substances into living cells |
US5981781A (en) | 1996-04-26 | 1999-11-09 | E. I. Du Pont De Nemours And Company | Soybean oil having high oxidative stability |
US6329571B1 (en) | 1996-10-22 | 2001-12-11 | Japan Tobacco, Inc. | Method for transforming indica rice |
US20040049813A1 (en) | 1998-05-11 | 2004-03-11 | Russell Booth John | Novel gene combinations that alter the quality and functionality of soybean oil |
US6365802B2 (en) | 1998-08-14 | 2002-04-02 | Calgene Llc | Methods for increasing stearate content in soybean oil |
US6323392B1 (en) | 1999-03-01 | 2001-11-27 | Pioneer Hi-Bred International, Inc. | Formation of brassica napus F1 hybrid seeds which exhibit a highly elevated oleic acid content and a reduced linolenic acid content in the endogenously formed oil of the seeds |
US20040216189A1 (en) | 2001-01-09 | 2004-10-28 | Nancy Houmard | Maize chloroplast aldolase promoter compositions and methods for use thereof |
US20160024512A1 (en) | 2001-07-06 | 2016-01-28 | Monsanto Technology Llc | Methods For Enhancing Segregation of Transgenes in Plants and Compositions Thereof |
US8115058B2 (en) | 2001-09-26 | 2012-02-14 | Syngenta Participations Ag | Rice promoters for regulation of plant expression |
WO2006121757A2 (fr) | 2005-05-05 | 2006-11-16 | Monsanto Technology, Llc | Plantes contenant un gene de flavohemoglobine heterologue et procedes d'utilisation desdites plantes |
US20080145511A1 (en) | 2005-06-23 | 2008-06-19 | Solae, Llc | Soy protein products having reduced off-flavor and processes for making the same |
US7638155B2 (en) | 2005-06-23 | 2009-12-29 | Solae, Llc | Process for making soy protein products having reduced off-flavor |
US20080008815A1 (en) | 2006-06-21 | 2008-01-10 | Cho Myong J | Bland tasting soy protein isolate and processes for making same |
US20080312082A1 (en) | 2006-10-31 | 2008-12-18 | Kinney Anthony J | Soybean event dp-305423-1 and compositions and methods for the identification and/or detection thereof |
US9828429B2 (en) | 2007-09-26 | 2017-11-28 | Chugai Seiyaku Kabushiki Kaisha | Method of modifying isoelectric point of antibody via amino acid substitution in CDR |
US9918485B2 (en) | 2007-12-21 | 2018-03-20 | E I Du Pont De Nemours And Company | Soy protein products having altered characteristics |
US20140193547A1 (en) | 2011-07-12 | 2014-07-10 | Maraxi, Inc. | Methods and compositions for consumables |
US9011949B2 (en) | 2011-07-12 | 2015-04-21 | Impossible Foods Inc. | Methods and compositions for consumables |
US9700067B2 (en) | 2011-07-12 | 2017-07-11 | Impossible Foods Inc. | Methods and compositions for affecting the flavor and aroma profile of consumables |
US10039306B2 (en) | 2012-03-16 | 2018-08-07 | Impossible Foods Inc. | Methods and compositions for consumables |
US20150305361A1 (en) | 2013-01-11 | 2015-10-29 | Impossible Foods Inc. | Methods and compositions for consumables |
US20160340411A1 (en) | 2013-01-11 | 2016-11-24 | Impossible Foods Inc. | Secretion of heme-containing polypeptides |
WO2015038796A2 (fr) | 2013-09-11 | 2015-03-19 | Impossible Foods Inc. | Sécrétion de polypeptides contenant un hème |
US10172380B2 (en) | 2014-03-31 | 2019-01-08 | Impossible Foods Inc. | Ground meat replicas |
WO2016054375A1 (fr) | 2014-10-01 | 2016-04-07 | Impossible Foods Inc. | Procédés d'extraction et de purification de protéines non dénaturées |
US20180127764A1 (en) | 2015-05-11 | 2018-05-10 | Impossible Foods Inc. | Expression constructs and methods of genetically engineering methylotrophic yeast |
WO2017218883A1 (fr) | 2016-06-17 | 2017-12-21 | Arcadia Biosciences, Inc. | Végétaux à activité de la lipase 1 réduite |
WO2018102656A1 (fr) | 2016-12-02 | 2018-06-07 | City Of Hope | Production de produits recombinés dans des systèmes contenus |
WO2018102721A1 (fr) | 2016-12-02 | 2018-06-07 | City Of Hope | Plantes transgéniques à biosynthèse d'hème régulée à la hausse |
US20190292555A1 (en) | 2016-12-02 | 2019-09-26 | Impossible Foods Inc. | Producing recombinant products in contained systems |
US20190292217A1 (en) | 2016-12-02 | 2019-09-26 | Impossible Foods Inc. | Transgenic plants with upregulated heme biosynthesis |
WO2019173125A1 (fr) | 2018-03-09 | 2019-09-12 | Pioneer Hi-Bred International, Inc. | Compositions et procédés de modification d'acides gras du soja |
WO2020106488A1 (fr) | 2018-11-19 | 2020-05-28 | Pioneer Hi-Bred International, Inc. | Gène de soja et son utilisation pour modifier une composition de graine |
US10660297B1 (en) | 2019-10-22 | 2020-05-26 | Syngenta Crop Protection Ag | Pea variety Snak Hero |
Non-Patent Citations (52)
Title |
---|
"GenBank", Database accession no. XP 014509945 |
"Uniprot", Database accession no. I1K551 |
ABLER, PLANT MOL. BIOL., vol. 22, 1993, pages 10131 - 1038 |
AOYAMACHUA, PLANT J., vol. 11, 1997, pages 605 - 612 |
BENFEY ET AL., THE EMBO JOURNAL, vol. 8, no. 8, 1989, pages 2195 - 2202 |
BOHNER, S.GATZ, MOL. GEN. GENET., vol. 264, 2001, pages 860 - 870 |
BRUCE ET AL., PLANT CELL, vol. 12, 2000, pages 65 - 80 |
CADDICK ET AL., NAT. BIOTECHNOL., vol. 16, 1998, pages 177 - 180 |
CHEN ET AL., DEV GENET., vol. 10, no. 2, 1989, pages 112 - 22 |
CLEMENTECAHOON, PLANT PHYSIOL., vol. 151, no. 3, 2009, pages 1030 - 1040 |
COMAI ET AL., PLANT PHYSIOL., vol. 98, 1992, pages 53 - 61 |
CZARNECKI ET AL., J EXP BOT, vol. 63, no. 4, 2012, pages 1675 - 1687 |
DAMODARANARORA, ANNU. REV. FOOD SCI. TECHNOL., vol. 4, 2013, pages 327 - 346 |
DATTA ET AL., PLANT MOL. BIOL., vol. 14, 1990, pages 285 - 286 |
DIETRICH ET AL., J. PLANT NUTR., vol. 8, 1992, pages 1061 - 1073 |
DING ET AL., BIOTECHNOL LETT., vol. 28, no. 12, 2006, pages 869 - 75 |
ESKELIN ET AL., PLANT BIOTECHNOLOGY, vol. 7, 2009, pages 657 - 672 |
GATZ ET AL., PLANT J., vol. 2, 1992, pages 397 - 404 |
HARADA ET AL., MOL. GEN. GENET., vol. 212, 1988, pages 466 - 473 |
HU ET AL., PLOSS ONE, vol. 12, no. 2, 2017, pages e0172296 |
KEDDIE ET AL., PLANT MOL BIOL., vol. 24, no. 2, 1994, pages 327 - 40 |
KEEGSTRACLINE, PLANT CELL, vol. 11, 1999, pages 557 - 570 |
KOO ET AL., PLANT J., vol. 37, 2004, pages 439 - 448 |
LIU ET AL., BMC BIOTECHNOL., vol. 11, 2011, pages 108 |
LIU ET AL., PLANT BIOTECH. J., vol. 11, 2013, pages 43 - 52 |
MARTINEZ ET AL., PLANT J., vol. 19, 1999, pages 559 - 569 |
METT ET AL., PROC. NATL ACAD. SCI. USA, vol. 90, 1993, pages 4567 - 4571 |
MOCHIZUKI ET AL., TRENDS PLANT SCI, vol. 15, no. 9, 2010, pages 488 - 498 |
NGUYEN ET AL., CURR GENOMICS, vol. 17, no. 3, 2016, pages 241 - 260 |
PADIDAM ET AL., TRANSGENIC RES., vol. 12, 2003, pages 101 - 109 |
PEREZ-GRAUGOLDBERG, PLANT CELL, vol. 1, no. 11, 1989, pages 1095 - 1109 |
PLANT, vol. 5, 1994, pages 493 - 505 |
REEDY ET AL., NUCLEIC ACIDS RESEARCH, vol. 36, 2008 |
REYNOLDSSMITH, PLANTMOL. BIOL., vol. 27, 1995, pages 487 - 497 |
ROSLAN ET AL., PLANT J., vol. 28, 2001, pages 225 - 235 |
SALTER ET AL., PLANT J., vol. 16, 1998, pages 127 - 132 |
SAMALOVA ET AL., PLANT J., vol. 41, 2005, pages 919 - 935 |
SHEN ET AL., SCIENTIFIC REPORTS, vol. 7, 2017, pages 46231 |
SHERIDAN, GENETICS, vol. 142, 1996, pages 1009 - 1020 |
SJODAHL, PLANTA, vol. 197, 1995, pages 264 - 271 |
SOSSOUNTZOVE ET AL., PLANT CELL, vol. 3, 1991, pages 923 - 933 |
TANIGUCHI ET AL., PLANT CELL PHYSIOL., vol. 41, no. 1, 2000, pages 42 - 48 |
URAO, PLANT MOL. BIOL., vol. 32, 1996, pages 571 - 57 |
VAN DEN BROECK ET AL., NATURE, vol. 313, 1985, pages 358 - 363 |
VOELKER ET AL., SCIENCE, vol. 257, no. 5066, 1992, pages 72 - 4 |
VOGELI-LANGE ET AL., PLANT J., vol. 5, 1994, pages 273 - 278 |
VOTHKNECHT ET AL., PHYTOCHEMISTRY, vol. 47, 1998, pages 513 - 519 |
WASHIO ET AL., PLANT PHYS., vol. 105, 1994, pages 1275 - 1280 |
WERNER ET AL., PROC NATL ACAD SCI USA, vol. 108, no. 34, 2011, pages 14061 - 14066 |
ZHANG ET AL., PLANT PHYSIOL., vol. 104, 1994, pages 857 - 864 |
ZHANG ET AL., SCI REP., vol. 5, 2015, pages 8584 |
ZUO ET AL., PLANT J., vol. 24, 2000, pages 265 - 273 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11401526B2 (en) | 2020-09-30 | 2022-08-02 | Nobell Foods, Inc. | Recombinant fusion proteins for producing milk proteins in plants |
US11685928B2 (en) | 2020-09-30 | 2023-06-27 | Nobell Foods, Inc. | Recombinant fusion proteins for producing milk proteins in plants |
US11840717B2 (en) | 2020-09-30 | 2023-12-12 | Nobell Foods, Inc. | Host cells comprising a recombinant casein protein and a recombinant kinase protein |
US11952606B2 (en) | 2020-09-30 | 2024-04-09 | Nobell Foods, Inc. | Food compositions comprising recombinant milk proteins |
US11359206B2 (en) | 2020-10-28 | 2022-06-14 | Pioneer Hi-Bred International, Inc. | Leghemoglobin in soybean |
US11965168B2 (en) | 2020-10-28 | 2024-04-23 | Pioneer Hi-Bred International, Inc. | Leghemoglobin in soybean |
CN114874929A (zh) * | 2022-06-10 | 2022-08-09 | 江南大学 | 一种高效合成血红素的毕赤酵母重组菌株的构建 |
CN114874929B (zh) * | 2022-06-10 | 2024-02-27 | 江南大学 | 一种高效合成血红素的毕赤酵母重组菌株的构建 |
WO2024003668A1 (fr) | 2022-06-29 | 2024-01-04 | Moolec Science Limited | Expression élevée de protéine héminique animale dans des plantes |
Also Published As
Publication number | Publication date |
---|---|
WO2022072846A3 (fr) | 2022-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022072846A2 (fr) | Plantes transgéniques ayant des profils d'acides gras modifiés et une biosynthèse d'hème régulée à la hausse | |
US20190292217A1 (en) | Transgenic plants with upregulated heme biosynthesis | |
AU2020251039B2 (en) | Plant expressing animal milk proteins | |
MX2009000757A (es) | Acido graso desaturasas de tetraselmis suecica. | |
CA2844239C (fr) | Procedes permettant d'accroitre l'assimilation de co2 et la production d'huile dans des organismes photosynthetiques | |
US20090099378A1 (en) | Generation of plants with altered oil content | |
WO2022072833A2 (fr) | Constructions d'expression et méthodes de modification génétique de cellules | |
US8367892B2 (en) | Generation of plants with altered protein, fiber, or oil content | |
WO2013027160A1 (fr) | Procédés pour augmenter la teneur en protéines, en huile, et/ou en acides aminés chez une plante | |
CA3158307A1 (fr) | Procedes d'amelioration d'organismes photosynthetiques | |
EP1981973A2 (fr) | Phosphopantetheinyl transferases de bacteries | |
US20130045323A1 (en) | Methods of increasing protein, oil, and/or amino acid content in a plant | |
US7705204B2 (en) | Generation of plants with altered oil content | |
CA2509840C (fr) | Production de plantes presentant une teneur en huile modifiee | |
US7663020B2 (en) | Generation of plants with altered oil content | |
WO2013027159A1 (fr) | Méthodes d'augmentation de la teneur en protéines, en huile et/ou en acides aminés d'une plante | |
MXPA06013905A (es) | Generacion de plantas con contenido alterado de aceite. | |
WO2005118821A2 (fr) | Generation de plantes a teneur en huile modifiee | |
US20060174374A1 (en) | Generation of plants with altered oil content | |
MXPA06013904A (es) | Generacion de plantas con contenido alterado de aceite. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21801317 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21801317 Country of ref document: EP Kind code of ref document: A2 |